Qipan Deng
Overview
Explore the profile of Qipan Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu X, Li W, Deng Q, Liu H, Wang X, Hu H, et al.
Blood
. 2020 Oct;
137(12):1615-1627.
PMID: 33025009
Myeloid differentiation primary response protein 88 (MYD88) is a critical universal adapter that transduces signaling from Toll-like and interleukin receptors to downstream nuclear factor-κB (NF-κB). MYD88L265P (leucine changed to proline...
2.
Yu X, Li W, Liu H, Deng Q, Wang X, Hu H, et al.
J Hematol Oncol
. 2020 May;
13(1):40.
PMID: 32357935
Background: Aberrant activation of DNA damage response (DDR) is a major cause of chemoresistance in colorectal cancer (CRC). CHK1 is upregulated in CRC and contributes to therapeutic resistance. We investigated...
3.
Zhang S, Gong Z, Oladimeji P, Currier D, Deng Q, Liu M, et al.
Exp Hematol Oncol
. 2019 Dec;
8:30.
PMID: 31788346
Background: Medulloblastoma is the most frequently occurring malignant brain tumor in children. Current treatment strategies for medulloblastoma include aggressive surgery, cranio-spinal irradiation and adjuvant chemotherapy. Because current treatments can cause...
4.
Deng Q, Hu H, Yu X, Liu S, Wang L, Chen W, et al.
Nat Commun
. 2019 Nov;
10(1):5061.
PMID: 31699989
A noncoding polymorphism (rs78378222) in TP53, carried by scores of millions of people, was previously associated with moderate risk of brain tumors and other neoplasms. We find a positive association...
5.
Wang L, Deng Q, Hu H, Liu M, Gong Z, Zhang S, et al.
J Hematol Oncol
. 2019 Jul;
12(1):70.
PMID: 31277689
Background: Glyphosate is the most widely used herbicide in the USA and worldwide. There has been considerable debate about its carcinogenicity. Epidemiological studies suggest that multiple myeloma (MM) and non-Hodgkin...
6.
Wang L, Kumar M, Deng Q, Wang X, Liu M, Gong Z, et al.
Cancer Lett
. 2018 Oct;
440-441:135-144.
PMID: 30343114
Although epidemiologic studies have suggested a possible association between occupational exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the risk of development of multiple myeloma, definitive evidence in support of this association is...
7.
Huang Q, Xi J, Wang L, Wang X, Ma X, Deng Q, et al.
J Hematol Oncol
. 2018 Jul;
11(1):90.
PMID: 29970126
The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.
8.
Yu X, Li W, Deng Q, Li L, Hsi E, Young K, et al.
Cancer Res
. 2018 Apr;
78(10):2457-2462.
PMID: 29703722
Next-generation sequencing has revealed cancer genomic landscapes, in which over 100 driver genes that, when altered by intragenic mutations, can promote oncogenesis. is a driver gene found in hematologic B-cell...
9.
Huang Q, Xia J, Wang L, Wang X, Ma X, Deng Q, et al.
J Hematol Oncol
. 2018 Apr;
11(1):58.
PMID: 29685162
Background: Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the first and rate-limiting step in converting tryptophan to kynurenine. Chimeric antigen receptor (CAR) T cells are T cells with recombinant receptors targeting tumor-associated...
10.
Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, et al.
Oncogene
. 2018 Mar;
37(23):3151-3165.
PMID: 29540832
MicroRNA-21 (miR-21) is one of the most abundant microRNAs in mammalian cells. It has been intensively studied for its role in regulating apoptosis and oncogenic transformation. However, the impact of...